| 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha) | HPV | Inactivated vaccine | | — | 3 |
| 13vPnC | Influenza | Inactivated vaccine | | — | 1 |
| 2009 H1N1 Virus | Influenza | Live attenuated vaccine | | — | 1 |
| 202-CoV | SARS-CoV-2 | Protein based vaccine | | — | 3 |
| 4-valent HPV vaccine | HPV | Synthetic vaccine | | — | 2 |
| A/17/California/66/395 (H2N2) | Influenza | Live attenuated vaccine | | — | 1 |
| A/17/mallard/Netherlands/00/95 (H7N3) | Influenza | Live attenuated vaccine | | — | 1 |
| A/17/turkey/Turkey/05/133 (H5N2) | Influenza | Live attenuated vaccine | | — | 2 |
| A/Anhui/1/2013 (H7N9) | Influenza | Virus-like particle vaccine | | — | 2 |
| A/Anhui/1/2013 (H7N9) x A/Ann Arbor/6/60 ca | Influenza | Live attenuated vaccine | | — | 1 |
| A/California/07/09 H1N1 | Influenza | Live attenuated vaccine | | P4 | 2 |
| A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca | Influenza | Live attenuated vaccine | | — | 2 |
| A/chicken/Hong Kong/G9/97 (H9N2) | Influenza | Inactivated vaccine | | — | 1 |
| A/H1N1 A/California/7/2009 NYMC X-179A | Influenza | Inactivated vaccine | | — | 2 |
| A/H3N2 variant Vaccine | Influenza | Inactivated vaccine | | — | 1 |
| A/H3N2v A/Minnesota/11/2010 NYMC X-203 | Influenza | Inactivated vaccine | | — | 1 |
| A/H5N1 | Influenza | Inactivated vaccine | | — | 7 |
| A/H5N1 A/Indonesia/05/2005 | Influenza | Inactivated vaccine | | — | 3 |
| A/H7N9 | Influenza | Inactivated vaccine | | — | 3 |
| A/H7N9 A/Shanghai/2/2013 | Influenza | Inactivated vaccine | | — | 3 |
| A/Indonesia/05/05 (H5N1) | Influenza | Virus-like particle vaccine | | — | 2 |
| A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca) | Influenza | Live attenuated vaccine | | — | 1 |
| a1DC + inactivated whole autologous HIV | HIV | Inactivated vaccine | | — | 1 |
| AAV5-RBD-S vaccine (BCD-250) | SARS-CoV-2 | Viral vector (Non-replicating) vaccine | | — | 1 |
| AAVLP-HPV | HPV | Virus-like particle vaccine | | — | 1 |